What's Happening?
EVERSANA recently hosted the 2026 Pharma Pricing & Access Innovation Conference (PPIC) in Basel, Switzerland, focusing on the evolving landscape of global pharmaceutical pricing and market access. The conference addressed the impact of policy initiatives
like Most Favoured Nations (MFN) and the EU’s Joint Clinical Assessment framework, which are reshaping market dynamics. Alan Crowther, EVERSANA’s general manager for global pricing and access, highlighted the shift in product launch strategies, with emerging markets like Brazil becoming priority launch sites over traditional Western markets. This shift is attributed to the changing calculus driven by MFN policies. The conference also explored the increasing complexity of drug pricing and access policies, which require companies to adapt to diverse and evolving regulations across different markets.
Why It's Important?
The developments discussed at the PPIC have significant implications for the pharmaceutical industry, particularly in terms of market strategy and regulatory compliance. The shift towards prioritizing emerging markets like Brazil for product launches could alter competitive dynamics and revenue streams for pharmaceutical companies. Additionally, the complexity of cross-border pricing policies necessitates a more sophisticated approach to market access, potentially increasing operational costs and requiring enhanced collaboration across policy, pricing, and access teams. The integration of AI in pricing strategies presents both opportunities for efficiency gains and challenges related to compliance with anticompetition laws, underscoring the need for careful implementation and monitoring.
What's Next?
As the pharmaceutical industry navigates these changes, companies will likely continue to refine their market access strategies, balancing the opportunities in emerging markets with the regulatory challenges in established ones. The role of AI in pricing and access is expected to grow, prompting companies to invest in AI capabilities while ensuring compliance with legal frameworks. Ongoing dialogue and collaboration among industry stakeholders, facilitated by conferences like PPIC, will be crucial in adapting to these shifts and maintaining competitive advantage.
